Fig. S8
Inhibition of brg1 impairs cardiac regeneration. (a-c) BrdU+/Mef2C+ proliferating cardiomyocyte were comparable between wt sibling hearts (a) and dn-xBrg1 transgenic hearts (b) at 14 dpa without heat shock treatment [(-) HS]. (c) Percentages of BrdU+/Mef2C+ cardiomyocytes in the injured area. (d-f) PCNA+/ Mef2C+ proliferating cardiomyocytes (arrowheads) decreased in dn-xBrg1 tg hearts (e) compared with wt sibling hearts (d) at 14 dpa with heat shock treatment. (f) Quantification of cardiomyocyte proliferation assessed by PCNA+/ Mef2C+ staining Scale bars, 100 μm. Data presented are mean ± s.e.m.; paired Student’s t-test, sample numbers are listed under each group, ** p < 0.01.